Cargando…
Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
Glioblastoma (GBM), the most lethal type of brain tumor in adults, has considerable cellular heterogeneity. The standard adjuvant chemotherapeutic agent for GBM, temozolomide (TMZ), has a modest response rate due to the development of drug resistance. Multiple studies have shown that valproic acid (...
Autores principales: | Tsai, Hong-Chieh, Wei, Kuo-Chen, Chen, Pin-Yuan, Huang, Chiung-Yin, Chen, Ko-Ting, Lin, Ya-Jui, Cheng, Hsiao-Wei, Chen, Yi-Rou, Wang, Hsiang-Tsui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518553/ https://www.ncbi.nlm.nih.gov/pubmed/34660288 http://dx.doi.org/10.3389/fonc.2021.722754 |
Ejemplares similares
-
Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
por: Chen, Jui-Chieh, et al.
Publicado: (2019) -
Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide: A nationwide population-based cohort study in Taiwan
por: Kuo, Yu-Jen, et al.
Publicado: (2020) -
Valproic Acid Downregulates the Expression of MGMT and Sensitizes Temozolomide-Resistant Glioma Cells
por: Ryu, Chung Heon, et al.
Publicado: (2012) -
Pharmacodynamic and Therapeutic Investigation of Focused Ultrasound-Induced Blood-Brain Barrier Opening for Enhanced Temozolomide Delivery in Glioma Treatment
por: Liu, Hao-Li, et al.
Publicado: (2014) -
Differential Characterization of Temozolomide-Resistant Human Glioma Cells
por: Lai, Sheng-Wei, et al.
Publicado: (2018)